Enzon Oncaspar Gains First-Line Leukemia Indication
This article was originally published in The Pink Sheet Daily
Pegaspargase allows for a more convenient dosing regimen than Merck's Elspar, the current standard of care for acute lymphoblastic leukemia, FDA says.
You may also be interested in...
FDA accepts a supplemental BLA for the pediatric acute lymphoblastic leukemia therapy, the firm announces Dec. 1.
Regeneron CEO Len Schleifer and President George Yancopoulos talked at the Stat Summit about launching their COVID-19 antibody cocktail and planning for the next pandemic.
The public health advocate and billionaire philanthropist raised issues about how a mass COVID-19 vaccination effort is being handled so far in the US, speaking at the Stat Summit.